Risultati di ricerca
Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial and cervical cancers who gain clinically meaningful benefit from adding immunotherapy to current standard treatments, while a first-in-human study found ‘promising’ antitumour activity with a novel antibody drug conjugate (ADC) targeting the protein claudin 6 in heavily pretreated patients with ovarian ...
The ESMO Expert Consensus Statement series of publications contain recommendations on well-defined, controversial or clinically relevant topics and are produced by 20-40 key experts in the field. ESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe.
13 set 2024 · ESMO 2024 disseminated the latest cutting-edge data, provided high quality education and excellent networking opportunities for oncologists and other stakeholders from all around the world. The innovative, LIVE Plus Congress format offered participants the option to attend in person, in Barcelona or online, through the Virtual Congress Platform ...
The ESMO Clinical Practice Guidelines on Early and Metastatic Breast Cancer cover information on screening, diagnosis, pathology and molecular biology, staging and risk assessment, disease management, monitoring and follow-up, palliative care and the patient perspective. There are also specific guidelines focusing on risk reduction and ...
ESMO Guidance for Reporting Oncology real-World Evidence (ESMO-GROW) ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) COVID-19 and Cancer: Registries, Studies and Surveys. ESMO Designated Centres of Integrated Oncology and Palliative Care. Palliative and Supportive Care Sessions at ESMO Congress 2022 Paris.
ESMO Guidance for Reporting Oncology real-World Evidence (ESMO-GROW) ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) COVID-19 and Cancer: Registries, Studies and Surveys. ESMO Designated Centres of Integrated Oncology and Palliative Care. Palliative and Supportive Care Sessions at ESMO Congress 2022 Paris.
ESMO’s core mission is to improve the quality of cancer care, from prevention and diagnosis all the way to palliative care and patient follow-up. It is to educate – doctors, cancer patients and the general public – on the best practices and latest advances in oncology. And it is to promote equal access to optimal cancer care for all patients.
Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to the ESMO Congress 2024. It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis. Presentation of accepted abstracts.
The ESMO 2024 Programme is now online! Access the online programme. A comprehensive educational and scientific programme will foster exchange and debate of translational cancer science, showcase first announcements of potentially practice changing data and stimulate multidisciplinary discussions to improve treatment options for our patients.
20 ott 2023 · DISCLAIMER ESMO is a scientific and professional, non-political and non-religious organisation. As such, and in light of the tragic events unfolding in so many parts of the world, ESMO will not accept responsibility for any comments or remarks made during the ESMO Congress 2023 by session chairs, invited speakers, presenters, members or any other contributor, formally or informally, which ...
